Current Status in Extracorporeal Immunomodulation: Immune Disorders
- 1 August 1996
- journal article
- review article
- Published by Wiley in Artificial Organs
- Vol. 20 (8) , 902-905
- https://doi.org/10.1111/j.1525-1594.1996.tb04567.x
Abstract
Today, clinicians can choose from a variety of extracorporeal immunomodulatory procedures such as plasma exchange, double filtration, immunoadsorption, chemoadsorption, photopheresis, and cytoapheresis. The mechanisms underlying extracorporeal immunomodulation (ECIM) comprise removal of pathogenic antibodies and circulating immune complexes as well as reticuloendothelial system deblockage; modification of immune complex structure and processing can be induced by changing the antigen/antibody ratio and by modulation of immune complex solubility via complement activation. Finally, cellular components like lymphocyte subsets, can be modified. Clinical examples of ECIM include lupus erythematosus, Goodpasture's syndrome, anti-neutrophil cytoplasmatic antibodies-mediated systemic vasculitis, myasthenia gravis, and, hypothetically, sepsis.Keywords
This publication has 15 references indexed in Scilit:
- Management of autoimmune disordersJournal of Clinical Apheresis, 1993
- A Controlled Trial of Plasmapheresis Therapy in Severe Lupus NephritisNew England Journal of Medicine, 1992
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991
- Septic Shock in HumansAnnals of Internal Medicine, 1990
- Thrombotic Thrombocytopenic Purpura: Successful Treatment Unlocks Etiologic SecretsMayo Clinic Proceedings, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Immunomodulation: Clinical AspectsArtificial Organs, 1986
- Therapy of Anti-Glomerular Basement Membrane Antibody DiseaseMedicine, 1985
- Reversal of Impaired Splenic Function in Patients with Nephritis or Vasculitis (or Both) by Plasma ExchangeNew England Journal of Medicine, 1979
- Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus ErythematosusNew England Journal of Medicine, 1979